{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,21]],"date-time":"2026-10-21T17:59:59Z","timestamp":1792605599435,"version":"4.5.0"},"reference-count":42,"publisher":"Elsevier BV","license":[{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2025,10,1]],"date-time":"2025-10-01T00:00:00Z","timestamp":1759276800000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2025,8,10]],"date-time":"2025-08-10T00:00:00Z","timestamp":1754784000000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by-nc\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82173406"],"award-info":[{"award-number":["82173406"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100016079","name":"Science and Technology Department of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","id":[{"id":"10.13039\/100016079","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013113","name":"Xingjiang Uighur Autonomous Region Talent Project","doi-asserted-by":"publisher","award":["2024TSYCCX0076"],"award-info":[{"award-number":["2024TSYCCX0076"]}],"id":[{"id":"10.13039\/501100013113","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100013113","name":"Xingjiang Uighur Autonomous Region Talent Project","doi-asserted-by":"publisher","award":["2022TSYCLJ0025"],"award-info":[{"award-number":["2022TSYCLJ0025"]}],"id":[{"id":"10.13039\/501100013113","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/100009110","name":"Natural Science Foundation of Xinjiang Uygur Autonomous Region","doi-asserted-by":"publisher","award":["2023D01C72"],"award-info":[{"award-number":["2023D01C72"]}],"id":[{"id":"10.13039\/100009110","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["clinicalkey.com","clinicalkey.com.au","clinicalkey.es","clinicalkey.fr","clinicalkey.jp","em-consulte.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Biomedicine &amp; Pharmacotherapy"],"published-print":{"date-parts":[[2025,10]]},"DOI":"10.1016\/j.biopha.2025.118456","type":"journal-article","created":{"date-parts":[[2025,8,13]],"date-time":"2025-08-13T00:55:03Z","timestamp":1755046503000},"page":"118456","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":1,"special_numbering":"C","title":["Isorhamnetin protects melanocytes against CD8+ T cell-mediated apoptosis and reduces inflammation in vitiligo-afflicted mouse"],"prefix":"10.1016","volume":"191","author":[{"given":"Wen","family":"Hu","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Hongjuan","family":"Wang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Zixian","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kaixiao","family":"Li","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yima","family":"Na","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xiaojing","family":"Kang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.biopha.2025.118456_bib1","doi-asserted-by":"crossref","first-page":"4910","DOI":"10.3390\/ijms24054910","article-title":"Vitiligo, from pathogenesis to therapeutic advances: state of the art","volume":"24","author":"Diotallevi","year":"2023","journal-title":"Int. J. Mol. Sci."},{"key":"10.1016\/j.biopha.2025.118456_bib2","article-title":"Research progress on targeted antioxidant therapy and vitiligo","volume":"2022","author":"Zhang","year":"2022","journal-title":"Oxid. Med. Cell. Longev."},{"key":"10.1016\/j.biopha.2025.118456_bib3","doi-asserted-by":"crossref","DOI":"10.3390\/biomedicines10071639","article-title":"Current concepts of vitiligo immunopathogenesis","volume":"10","author":"Hla\u010da","year":"2022","journal-title":"Biomedicines"},{"key":"10.1016\/j.biopha.2025.118456_bib4","doi-asserted-by":"crossref","first-page":"608","DOI":"10.1111\/ijd.13198","article-title":"Quality of life in patients with vitiligo: an analysis of the dermatology life quality index outcome over the past two decades","volume":"55","author":"Amer","year":"2016","journal-title":"Int. J. Dermatol."},{"key":"10.1016\/j.biopha.2025.118456_bib5","article-title":"Leptin deficiency in CD8+ t cells ameliorates non-segmental vitiligo by reducing interferon-\u03b3 and granzyme b","volume":"14","author":"Wu","year":"2023","journal-title":"Front. Immunol."},{"key":"10.1016\/j.biopha.2025.118456_bib6","doi-asserted-by":"crossref","first-page":"31","DOI":"10.1186\/s13619-022-00132-9","article-title":"A mouse model of vitiligo based on endogenous auto-reactive CD8 + t cell targeting skin melanocyte","volume":"11","author":"Chen","year":"2022","journal-title":"Cell Regen."},{"key":"10.1016\/j.biopha.2025.118456_bib7","doi-asserted-by":"crossref","first-page":"78","DOI":"10.1016\/j.jdermsci.2023.04.006","article-title":"Targeting the elevated IFN-\u03b3 in vitiligo patients by human anti- IFN-\u03b3 monoclonal antibody hampers direct cytotoxicity in melanocyte","volume":"110","author":"Ng","year":"2023","journal-title":"J. Dermatol. Sci."},{"key":"10.1016\/j.biopha.2025.118456_bib8","doi-asserted-by":"crossref","first-page":"84","DOI":"10.1002\/path.6073","article-title":"MIF inhibition alleviates vitiligo progression by suppressing CD8+ t cell activation and proliferation","volume":"260","author":"Chen","year":"2023","journal-title":"J. Pathol."},{"key":"10.1016\/j.biopha.2025.118456_bib9","doi-asserted-by":"crossref","first-page":"614","DOI":"10.1016\/j.fct.2019.02.014","article-title":"Isorhamnetin and its new derivatives isolated from sea buckthorn berries prevent H2O2\/Fe - induced oxidative stress and changes in hemostasis","volume":"125","author":"Skalski","year":"2019","journal-title":"Food Chem. Toxicol."},{"key":"10.1016\/j.biopha.2025.118456_bib10","doi-asserted-by":"crossref","DOI":"10.1016\/j.biopha.2020.110301","article-title":"Isorhamnetin: a review of pharmacological effects","volume":"128","author":"Gong","year":"2020","journal-title":"Biomed. Pharm."},{"key":"10.1016\/j.biopha.2025.118456_bib11","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24030390","article-title":"Isorhamnetin, hispidulin, and cirsimaritin identified in tamarix ramosissima barks from Southern xinjiang and their antioxidant and antimicrobial activities","volume":"24","author":"Ren","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118456_bib12","doi-asserted-by":"crossref","first-page":"1011","DOI":"10.1016\/j.sjbs.2019.04.002","article-title":"Isorhamnetin in tsoong blocks Hsp70 expression to promote apoptosis of colon cancer cells","volume":"26","author":"Luan","year":"2019","journal-title":"Saudi J. Biol. Sci."},{"key":"10.1016\/j.biopha.2025.118456_bib13","doi-asserted-by":"crossref","DOI":"10.3390\/molecules24213984","article-title":"Isorhamnetin has potential for the treatment of escherichia coli-induced sepsis","volume":"24","author":"Chauhan","year":"2019","journal-title":"Molecules"},{"key":"10.1016\/j.biopha.2025.118456_bib14","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1002\/ddr.21815","article-title":"Potential antiviral activity of isorhamnetin against SARS-CoV-2 spike pseudotyped virus in vitro","volume":"82","author":"Zhan","year":"2021","journal-title":"Drug Dev. Res."},{"key":"10.1016\/j.biopha.2025.118456_bib15","doi-asserted-by":"crossref","first-page":"70","DOI":"10.1016\/j.crfs.2019.11.002","article-title":"Fat-lowering effects of isorhamnetin are via NHR-49-dependent pathway in caenorhabditis elegans","volume":"2","author":"Farias-Pereira","year":"2020","journal-title":"Curr. Res Food Sci."},{"key":"10.1016\/j.biopha.2025.118456_bib16","doi-asserted-by":"crossref","first-page":"103","DOI":"10.1186\/s12918-017-0486-1","article-title":"Network pharmacological mechanisms of vernonia anthelmintica (L.) in the treatment of vitiligo: isorhamnetin induction of melanogenesis via up-regulation of melanin-biosynthetic genes","volume":"11","author":"Wang","year":"2017","journal-title":"BMC Syst. Biol."},{"key":"10.1016\/j.biopha.2025.118456_bib17","doi-asserted-by":"crossref","first-page":"2498","DOI":"10.1038\/s41598-023-27575-7","article-title":"Protective effects of isorhamnetin against H2O2-induced oxidative damage in HaCaT cells and comprehensive analysis of key genes","volume":"13","author":"Hu","year":"2023","journal-title":"Sci. Rep."},{"key":"10.1016\/j.biopha.2025.118456_bib18","doi-asserted-by":"crossref","first-page":"1143","DOI":"10.1016\/j.jid.2019.11.013","article-title":"NKG2D defines a subset of skin effector memory CD8 t cells with proinflammatory functions in vitiligo","volume":"140","author":"Jacquemin","year":"2020","journal-title":"J. Invest. Dermatol."},{"issue":"1","key":"10.1016\/j.biopha.2025.118456_bib19","doi-asserted-by":"crossref","first-page":"237","DOI":"10.3892\/mmr.2012.1117","article-title":"CD8+ t cells from vitiligo perilesional margins induce autologous melanocyte apoptosis","volume":"7","author":"Wu","year":"2012","journal-title":"MOL MED REP"},{"key":"10.1016\/j.biopha.2025.118456_bib20","doi-asserted-by":"crossref","first-page":"217","DOI":"10.1080\/01913123.2022.2044946","article-title":"Melanocytes and keratinocytes morphological changes in vitiligo patients. A histological, immunohistochemical and ultrastructural analysis","volume":"46","author":"Elsherif","year":"2022","journal-title":"Ultrastruct. Pathol."},{"key":"10.1016\/j.biopha.2025.118456_bib21","doi-asserted-by":"crossref","first-page":"1507","DOI":"10.1111\/jdv.18129","article-title":"The humanistic burden of vitiligo: a systematic literature review of quality-of-life outcomes, J. Eur","volume":"36","author":"Picardo","year":"2022","journal-title":"Acad. Dermatol. Venereol."},{"key":"10.1016\/j.biopha.2025.118456_bib22","doi-asserted-by":"crossref","first-page":"1371","DOI":"10.1016\/j.jaad.2018.11.047","article-title":"Vitiligo and major depressive disorder: a bidirectional population-based cohort study","volume":"80","author":"Vallerand","year":"2019","journal-title":"J. Am. Acad. Dermatol."},{"key":"10.1016\/j.biopha.2025.118456_bib23","doi-asserted-by":"crossref","first-page":"20","DOI":"10.1186\/s12955-020-1278-7","article-title":"Evaluating prevalence of depression, anxiety and hopelessness in patients with vitiligo on an Iranian population","volume":"18","author":"Hamidizadeh","year":"2020","journal-title":"Health Qual. Life Outcomes"},{"key":"10.1016\/j.biopha.2025.118456_bib24","doi-asserted-by":"crossref","first-page":"683","DOI":"10.1111\/pcmr.12935","article-title":"Type I interferon signaling limits viral vector priming of CD8+ t cells during initiation of vitiligo and melanoma immunotherapy","volume":"34","author":"Riding","year":"2021","journal-title":"Pigment Cell Melanoma Res"},{"key":"10.1016\/j.biopha.2025.118456_bib25","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2022.109574","article-title":"Overexpressed perforin contributes to the melanocyte destruction via epigenetic regulation in patients with vitiligo","volume":"114","author":"Deng","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.biopha.2025.118456_bib26","doi-asserted-by":"crossref","first-page":"1311","DOI":"10.1007\/s00011-024-01900-w","article-title":"The role of regulatory t cells in vitiligo and therapeutic advances: a mini-review","volume":"73","author":"Jin","year":"2024","journal-title":"Inflamm. Res."},{"key":"10.1016\/j.biopha.2025.118456_bib27","doi-asserted-by":"crossref","first-page":"664","DOI":"10.2340\/00015555-2080","article-title":"Interferon-gamma inhibits melanogenesis and induces apoptosis in melanocytes: a pivotal role of CD8+ cytotoxic t lymphocytes in vitiligo","volume":"95","author":"Yang","year":"2015","journal-title":"Acta Derm. Venereol."},{"key":"10.1016\/j.biopha.2025.118456_bib28","doi-asserted-by":"crossref","first-page":"2220","DOI":"10.1038\/jid.2009.32","article-title":"Autoimmune destruction of skin melanocytes by perilesional t cells from vitiligo patients","volume":"129","author":"Van den Boorn","year":"2009","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2025.118456_bib29","doi-asserted-by":"crossref","first-page":"550","DOI":"10.1046\/j.1523-1747.2003.12413.x","article-title":"Cytotoxic t lymphocyte reactivity to gp100, MelanA\/MART-1, and tyrosinase, in HLA-A2-positive vitiligo patients","volume":"121","author":"Mandelcorn-Monson","year":"2003","journal-title":"J. Invest. Dermatol."},{"key":"10.1016\/j.biopha.2025.118456_bib30","doi-asserted-by":"crossref","first-page":"621","DOI":"10.1146\/annurev-immunol-100919-023531","article-title":"Vitiligo: mechanisms of pathogenesis and treatment","volume":"38","author":"Frisoli","year":"2020","journal-title":"Annu. Rev. Immunol."},{"key":"10.1016\/j.biopha.2025.118456_bib31","doi-asserted-by":"crossref","first-page":"123","DOI":"10.1007\/s00403-019-01996-9","article-title":"Predominant role of innate pro-inflammatory cytokines in vitiligo disease","volume":"312","author":"Gholijani","year":"2020","journal-title":"Arch. Dermatol. Res."},{"key":"10.1016\/j.biopha.2025.118456_bib32","doi-asserted-by":"crossref","first-page":"89","DOI":"10.1111\/ced.14374","article-title":"Increased expression of toll-like receptor 7 and 9 in vitiligo melanocytes: a pilot study","volume":"46","author":"Yu","year":"2021","journal-title":"Clin. Exp. Dermatol."},{"key":"10.1016\/j.biopha.2025.118456_bib33","doi-asserted-by":"crossref","first-page":"1487","DOI":"10.1080\/13685538.2020.1806814","article-title":"Levels of TNF-\u03b1, IL-6, IL-17, IL-37 cytokines in patients with active vitiligo","volume":"23","author":"Karag\u00fcn","year":"2020","journal-title":"Aging Male"},{"key":"10.1016\/j.biopha.2025.118456_bib34","doi-asserted-by":"crossref","DOI":"10.1172\/jci.insight.154585","article-title":"Multimodal analyses of vitiligo skin identify tissue characteristics of stable disease","volume":"7","author":"Shiu","year":"2022","journal-title":"JCI Insight"},{"key":"10.1016\/j.biopha.2025.118456_bib35","doi-asserted-by":"crossref","first-page":"117","DOI":"10.1016\/j.anndiagpath.2014.01.002","article-title":"Immunohistochemical expression of aberrant Notch-1 signaling in vitiligo: an implication for pathogenesis","volume":"18","author":"Seleit","year":"2014","journal-title":"Ann. Diagn. Pathol."},{"key":"10.1016\/j.biopha.2025.118456_bib36","doi-asserted-by":"crossref","first-page":"752","DOI":"10.1111\/exd.14761","article-title":"KRT5 mutation regulate melanin metabolism through notch signalling pathway between keratinocytes and melanocytes","volume":"32","author":"Jia","year":"2023","journal-title":"Exp. Dermatol."},{"key":"10.1016\/j.biopha.2025.118456_bib37","doi-asserted-by":"crossref","first-page":"2634","DOI":"10.1158\/0008-5472.CAN-18-2316","article-title":"Cross-talk between receptor tyrosine kinases AXL and ERBB3 regulates invadopodia formation in melanoma cells","volume":"79","author":"Revach","year":"2019","journal-title":"Cancer Res"},{"key":"10.1016\/j.biopha.2025.118456_bib38","doi-asserted-by":"crossref","first-page":"868","DOI":"10.1002\/cac2.12334","article-title":"The E3 ubiquitin ligase HUWE1 acts through the N-Myc-DLL1-NOTCH1 signaling axis to suppress glioblastoma progression","volume":"42","author":"Yuan","year":"2023","journal-title":"Cancer Commun"},{"key":"10.1016\/j.biopha.2025.118456_bib39","doi-asserted-by":"crossref","first-page":"593","DOI":"10.1186\/s12864-019-5967-8","article-title":"Gene expression profile of human t cells following a single stimulation of peripheral blood mononuclear cells with anti-CD3 antibodies","volume":"20","author":"Sousa","year":"2019","journal-title":"BMC Genom."},{"key":"10.1016\/j.biopha.2025.118456_bib40","doi-asserted-by":"crossref","unstructured":"A.Mohamed Amer, Correlation between vitamin D and interleukin \u2013 21, in: Patients Vitiligo CDT. 5 (2019) 1\u20134.","DOI":"10.24966\/CDT-8771\/100039"},{"key":"10.1016\/j.biopha.2025.118456_bib41","doi-asserted-by":"crossref","DOI":"10.1016\/j.jaut.2021.102689","article-title":"New developments implicating IL-21 in autoimmune disease","volume":"122","author":"Ren","year":"2021","journal-title":"J. Autoimmun."},{"key":"10.1016\/j.biopha.2025.118456_bib42","doi-asserted-by":"crossref","first-page":"564","DOI":"10.3389\/fcell.2020.00564","article-title":"CD226: an emerging role in immunologic diseases","volume":"8","author":"Huang","year":"2020","journal-title":"Front. Cell Dev. Biol."}],"container-title":["Biomedicine &amp; Pharmacotherapy"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500650X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S075333222500650X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,3,6]],"date-time":"2026-03-06T14:21:41Z","timestamp":1772806901000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S075333222500650X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2025,10]]},"references-count":42,"alternative-id":["S075333222500650X"],"URL":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118456","relation":{},"ISSN":["0753-3322"],"issn-type":[{"value":"0753-3322","type":"print"}],"subject":[],"published":{"date-parts":[[2025,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Isorhamnetin protects melanocytes against CD8+ T cell-mediated apoptosis and reduces inflammation in vitiligo-afflicted mouse","name":"articletitle","label":"Article Title"},{"value":"Biomedicine & Pharmacotherapy","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.biopha.2025.118456","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2025 The Author(s). Published by Elsevier Masson SAS.","name":"copyright","label":"Copyright"}],"article-number":"118456"}}